TY - JOUR
T1 - Arthrocentesis and Joint Injection in Patients Receiving Direct Oral Anticoagulants
AU - Yui, Jennifer C.
AU - Preskill, Carina
AU - Greenlund, Laura S.
N1 - Publisher Copyright:
© 2017 Mayo Foundation for Medical Education and Research
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2017/8
Y1 - 2017/8
N2 - Anticoagulation is common in patients undergoing arthrocentesis and joint injections. Previous studies have established the safety of continuing anticoagulation with warfarin before joint aspirations/injections with only a small increased risk of bleeding, but no data are available regarding the use of direct oral anticoagulants (DOACs) and joint aspirations/injections. The objective of this study was to determine the rate of bleeding complications associated with arthrocentesis and joint injection in patients receiving DOACs. We performed a retrospective review of adult patients at Mayo Clinic in Rochester, Minnesota, who were being treated with DOACs and underwent outpatient joint aspiration and/or injection between October 1, 2010, and October 31, 2016. In 1050 consecutive procedures, there were no bleeding complications. Arthrocentesis and joint injections in patients receiving DOAC therapy are safe procedures, and there is no need to withhold anticoagulation treatment before the procedure.
AB - Anticoagulation is common in patients undergoing arthrocentesis and joint injections. Previous studies have established the safety of continuing anticoagulation with warfarin before joint aspirations/injections with only a small increased risk of bleeding, but no data are available regarding the use of direct oral anticoagulants (DOACs) and joint aspirations/injections. The objective of this study was to determine the rate of bleeding complications associated with arthrocentesis and joint injection in patients receiving DOACs. We performed a retrospective review of adult patients at Mayo Clinic in Rochester, Minnesota, who were being treated with DOACs and underwent outpatient joint aspiration and/or injection between October 1, 2010, and October 31, 2016. In 1050 consecutive procedures, there were no bleeding complications. Arthrocentesis and joint injections in patients receiving DOAC therapy are safe procedures, and there is no need to withhold anticoagulation treatment before the procedure.
UR - http://www.scopus.com/inward/record.url?scp=85025470301&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85025470301&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2017.04.007
DO - 10.1016/j.mayocp.2017.04.007
M3 - Article
C2 - 28778256
AN - SCOPUS:85025470301
SN - 0025-6196
VL - 92
SP - 1223
EP - 1226
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 8
ER -